These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29690995)

  • 21. Haptoglobin HP2-2 genotype, alpha-thalassaemia and acute seizures in children living in a malaria-endemic area.
    Idro R; Williams TN; Gwer S; Uyoga S; Macharia A; Opi H; Atkinson S; Maitland K; Kager PA; Kwiatkowski D; Neville BG; Newton CR
    Epilepsy Res; 2008 Oct; 81(2-3):114-8. PubMed ID: 18554871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the Kna/Knb polymorphism and a method for Knops genotyping.
    Moulds JM; Thomas BJ; Doumbo O; Diallo DA; Lyke KE; Plowe CV; Rowe JA; Birmingham DJ
    Transfusion; 2004 Feb; 44(2):164-9. PubMed ID: 14962306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A complement receptor-1 polymorphism with high frequency in malaria endemic regions of Asia but not Africa.
    Thomas BN; Donvito B; Cockburn I; Fandeur T; Rowe JA; Cohen JH; Moulds JM
    Genes Immun; 2005 Feb; 6(1):31-6. PubMed ID: 15578041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.
    McGuire W; Hill AV; Allsopp CE; Greenwood BM; Kwiatkowski D
    Nature; 1994 Oct; 371(6497):508-10. PubMed ID: 7935762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study.
    Lopera-Mesa TM; Doumbia S; Konaté D; Anderson JM; Doumbouya M; Keita AS; Diakité SA; Traoré K; Krause MA; Diouf A; Moretz SE; Tullo GS; Miura K; Gu W; Fay MP; Taylor SM; Long CA; Diakité M; Fairhurst RM
    Lancet Haematol; 2015 Apr; 2(4):e140-9. PubMed ID: 26687956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased microerythrocyte count in homozygous alpha(+)-thalassaemia contributes to protection against severe malarial anaemia.
    Fowkes FJ; Allen SJ; Allen A; Alpers MP; Weatherall DJ; Day KP
    PLoS Med; 2008 Mar; 5(3):e56. PubMed ID: 18351796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia.
    Odhiambo CO; Otieno W; Adhiambo C; Odera MM; Stoute JA
    BMC Med; 2008 Aug; 6():23. PubMed ID: 18717995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria.
    Cockburn IA; Mackinnon MJ; O'Donnell A; Allen SJ; Moulds JM; Baisor M; Bockarie M; Reeder JC; Rowe JA
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):272-7. PubMed ID: 14694201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographical distribution of complement receptor type 1 variants and their associated disease risk.
    Lucas Sandri T; Adukpo S; Giang DP; Nguetse CN; Antunes Andrade F; Tong HV; Toan NL; Song LH; Elumalai P; Thangaraj K; Valluri VL; Ntoumi F; Meyer CG; Jose de Messias Reason I; Kremsner PG; Velavan TP
    PLoS One; 2017; 12(5):e0175973. PubMed ID: 28520715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor polymorphisms and cerebral malaria: TLR2 Δ22 polymorphism is associated with protection from cerebral malaria in a case control study.
    Greene JA; Sam-Agudu N; John CC; Opoka RO; Zimmerman PA; Kazura JW
    Malar J; 2012 Feb; 11():47. PubMed ID: 22336003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related changes in red blood cell complement regulatory proteins and susceptibility to severe malaria.
    Waitumbi JN; Donvito B; Kisserli A; Cohen JH; Stoute JA
    J Infect Dis; 2004 Sep; 190(6):1183-91. PubMed ID: 15319870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa.
    Cooke GS; Aucan C; Walley AJ; Segal S; Greenwood BM; Kwiatkowski DP; Hill AV
    Am J Trop Med Hyg; 2003 Dec; 69(6):565-8. PubMed ID: 14740869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased survival in B-cell-deficient mice during experimental cerebral malaria suggests a role for circulating immune complexes.
    de Oliveira RB; Wang JP; Ram S; Gazzinelli RT; Finberg RW; Golenbock DT
    mBio; 2014 Mar; 5(2):e00949-14. PubMed ID: 24643866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between erythrocyte polymorphisms and risks of uncomplicated and severe malaria in Ugandan children: A case control study.
    Mpimbaza A; Walakira A; Ndeezi G; Katahoire A; Karamagi C; Nsobya SL; Tukwasibwe S; Asua V; Rosenthal PJ
    PLoS One; 2018; 13(9):e0203229. PubMed ID: 30222732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An investigation of the protective effect of alpha+-thalassaemia against severe Plasmodium falciparum amongst children in Kumasi, Ghana.
    Opoku-Okrah C; Gordge M; Kweku Nakua E; Abgenyega T; Parry M; Robertson C; Smith CL
    Int J Lab Hematol; 2014 Feb; 36(1):62-70. PubMed ID: 23837700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative epistasis between α+ thalassaemia and sickle cell trait can explain interpopulation variation in South Asia.
    Penman BS; Habib S; Kanchan K; Gupta S
    Evolution; 2011 Dec; 65(12):3625-32. PubMed ID: 22133230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour necrosis factor alpha promoter polymorphism, TNF-238 is associated with severe clinical outcome of falciparum malaria in Ibadan southwest Nigeria.
    Olaniyan SA; Amodu OK; Bakare AA; Troye-Blomberg M; Omotade OO; Rockett KA;
    Acta Trop; 2016 Sep; 161():62-7. PubMed ID: 27178813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision.
    Watson JA; Ndila CM; Uyoga S; Macharia A; Nyutu G; Mohammed S; Ngetsa C; Mturi N; Peshu N; Tsofa B; Rockett K; Leopold S; Kingston H; George EC; Maitland K; Day NP; Dondorp AM; Bejon P; Williams TN; Holmes CC; White NJ
    Elife; 2021 Jul; 10():. PubMed ID: 34225842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.
    Hobbs MR; Udhayakumar V; Levesque MC; Booth J; Roberts JM; Tkachuk AN; Pole A; Coon H; Kariuki S; Nahlen BL; Mwaikambo ED; Lal AL; Granger DL; Anstey NM; Weinberg JB
    Lancet; 2002 Nov; 360(9344):1468-75. PubMed ID: 12433515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.